메뉴 건너뛰기




Volumn 21, Issue 6, 1998, Pages 548-552

A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer

Author keywords

Chemotherapy; Colorectal carcinoma; Paclitaxel

Indexed keywords

PACLITAXEL;

EID: 0031795545     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199812000-00004     Document Type: Article
Times cited : (13)

References (22)
  • 2
    • 0026721532 scopus 로고
    • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
    • The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
    • (1992) J Clin Oncol , vol.10 , pp. 896-903
  • 4
    • 0019399125 scopus 로고
    • New natural products under development at the National Cancer Institute
    • Douros J, Suffness M. New natural products under development at the National Cancer Institute. Recent Results Cancer Res 1981;76:153-75.
    • (1981) Recent Results Cancer Res , vol.76 , pp. 153-175
    • Douros, J.1    Suffness, M.2
  • 5
    • 0026767740 scopus 로고
    • Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells
    • Hanauske A-R, Degen D, Hilsenbeck SG, et al. Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 1992;3:121-4.
    • (1992) Anti-Cancer Drugs , vol.3 , pp. 121-124
    • Hanauske, A.-R.1    Degen, D.2    Hilsenbeck, S.G.3
  • 6
    • 0027791909 scopus 로고
    • Taxol-base combination chemotherapy and other in vivo preclinical antitumor studies
    • Rose WC. Taxol-base combination chemotherapy and other in vivo preclinical antitumor studies. Monogr Natl Cancer Inst 1993;15:47-53.
    • (1993) Monogr Natl Cancer Inst , vol.15 , pp. 47-53
    • Rose, W.C.1
  • 7
    • 0029622442 scopus 로고
    • Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue
    • Matsuoka H, Yano K, Saito T, et al. Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue. Anticancer Res 1995;15:2001-6.
    • (1995) Anticancer Res , vol.15 , pp. 2001-2006
    • Matsuoka, H.1    Yano, K.2    Saito, T.3
  • 8
    • 0023261546 scopus 로고
    • Phase I clinical and pharmacokinetic study of taxol
    • Wiernik PH, Schwartz EL, Strauman JJ, et al. Phase I clinical and pharmacokinetic study of taxol. Cancer Res 1987;47:2946-93.
    • (1987) Cancer Res , vol.47 , pp. 2946-2993
    • Wiernik, P.H.1    Schwartz, E.L.2    Strauman, J.J.3
  • 9
    • 0026723301 scopus 로고
    • Taxol: The first of the taxanes, an important new class of antitumor agents
    • Rowinsky EK, Onetto N, Canetta RM, et al. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992;19:646-62.
    • (1992) Semin Oncol , vol.19 , pp. 646-662
    • Rowinsky, E.K.1    Onetto, N.2    Canetta, R.M.3
  • 10
    • 0027238859 scopus 로고
    • Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
    • Lopes NM, Adams EG, Petts TW, et al. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 1993;32:235-42.
    • (1993) Cancer Chemother Pharmacol , vol.32 , pp. 235-242
    • Lopes, N.M.1    Adams, E.G.2    Petts, T.W.3
  • 11
    • 0042132423 scopus 로고
    • Expression of a multidrug resistance gene in human tumors and tissues
    • Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-9.
    • (1987) Proc Natl Acad Sci USA , vol.84 , pp. 265-269
    • Fojo, A.T.1    Ueda, K.2    Slamon, D.J.3
  • 12
    • 0026050325 scopus 로고
    • P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines
    • Lai GM, Chen YN, Mickley LA, et al. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer 1991;49:696-703.
    • (1991) Int J Cancer , vol.49 , pp. 696-703
    • Lai, G.M.1    Chen, Y.N.2    Mickley, L.A.3
  • 13
    • 0025115739 scopus 로고
    • Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
    • Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-4.
    • (1990) Proc Natl Acad Sci USA , vol.87 , pp. 7160-7164
    • Noonan, K.E.1    Beck, C.2    Holzmayer, T.A.3
  • 14
    • 0028110931 scopus 로고
    • Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/II trial of 96-hr infusion
    • Wilson WH, Berg S, Bryant G, et al. Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hr infusion. J Clin Oncol 1994;12:1621-9.
    • (1994) J Clin Oncol , vol.12 , pp. 1621-1629
    • Wilson, W.H.1    Berg, S.2    Bryant, G.3
  • 15
    • 0028817461 scopus 로고
    • Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas
    • Wilson WH, Chabner BA, Bryant G, et al. Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. J Clin Oncol 1995;13:381-6.
    • (1995) J Clin Oncol , vol.13 , pp. 381-386
    • Wilson, W.H.1    Chabner, B.A.2    Bryant, G.3
  • 16
    • 0029946928 scopus 로고    scopus 로고
    • Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
    • Seidman AD, Hochhauser D, Gollub M, et al. Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. J Clin Oncol 1996;14:1877-84.
    • (1996) J Clin Oncol , vol.14 , pp. 1877-1884
    • Seidman, A.D.1    Hochhauser, D.2    Gollub, M.3
  • 17
    • 0027954464 scopus 로고
    • Taxol metabolism by human liver microsomes: Identification of cytochrome P-450 isozymes involved in its biotransformation
    • Cresteil T, Monsarrat B, Alvinerie P, et al. Taxol metabolism by human liver microsomes: identification of cytochrome P-450 isozymes involved in its biotransformation. Cancer Res 1994;54:386-92.
    • (1994) Cancer Res , vol.54 , pp. 386-392
    • Cresteil, T.1    Monsarrat, B.2    Alvinerie, P.3
  • 18
    • 0027137936 scopus 로고
    • Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model
    • Sharma A, Mayhew E, Straubinger RM. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res 1993;53:5877-81.
    • (1993) Cancer Res , vol.53 , pp. 5877-5881
    • Sharma, A.1    Mayhew, E.2    Straubinger, R.M.3
  • 19
    • 10144251769 scopus 로고    scopus 로고
    • Syntheses and structure-activity relationships of the second-generation antitumor taxoids: Exceptional activity against drug-resistant cancer cells
    • Ojima I, Slater JC, Michaud E, et al. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem 1996;39:3889-96.
    • (1996) J Med Chem , vol.39 , pp. 3889-3896
    • Ojima, I.1    Slater, J.C.2    Michaud, E.3
  • 20
    • 0029919598 scopus 로고    scopus 로고
    • Irinotecan (CPT-11) is an active agent in untreated patients with metastatic colorectal cancer
    • Conti JA, Kemeny N, Saltz L, et al. Irinotecan (CPT-11) is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 1996;14:709-15.
    • (1996) J Clin Oncol , vol.14 , pp. 709-715
    • Conti, J.A.1    Kemeny, N.2    Saltz, L.3
  • 21
    • 0029931840 scopus 로고    scopus 로고
    • Tomudex: A novel thymidylate synthase inhibitor with clinical antitumor activity in a range of solid tumors
    • Cunningham D, Zalcberg J, Smith IE, et al. Tomudex: a novel thymidylate synthase inhibitor with clinical antitumor activity in a range of solid tumors. Ann Oncol 1996;7:179-82.
    • (1996) Ann Oncol , vol.7 , pp. 179-182
    • Cunningham, D.1    Zalcberg, J.2    Smith, I.E.3
  • 22
    • 0031051207 scopus 로고    scopus 로고
    • Adjuvant treatment of colorectal cancer
    • Saltz LB, Kelsen DP. Adjuvant treatment of colorectal cancer. Annu Rev Med 1997;48:191-202.
    • (1997) Annu Rev Med , vol.48 , pp. 191-202
    • Saltz, L.B.1    Kelsen, D.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.